teaser
Drug giant AstraZeneca’s bipolar disorder treatment Seroquel – which is used alongside antidepressants to combat major depressive disorders (MDD) – has been approved by the US Food and Drug Administration (FDA).
A large amount of MDD sufferers do not respond well enough to treatment from antidepressants, say Astra – which is where Seroquel can help doctors follow a different course of action.
The FDA has written to Astra requesting additional information on treating MDD solely using Seroquel.
↓Article continues below this sponsored advert↓
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
↑Advertisement↑
News of Seroquel’s approval comes the day after Astra announced it is to licence TC-5214, also used to treat MDD, developed by biopharmaceutical company Targacept.
Copyright Press Association 2009
